17-Mar-16 India’s largest doctor discovery platform Practo has launched services in Brazil, its sixth location. This makes it one of the few homegrown Indian consumer Internet startups to capitalize on high-growth global markets. Practo is already present in Singapore, the Philippines, Malaysia and Indonesia. [image: Practo]

17-Mar-16 The Indian government has banned around 344 fixed dosed combination drugs, including Pfizer's cough syrup Corex, Procter & Gamble's Vicks Action 500 Extra and Crocin Cold and Flu, citing their potential risks. [image: Sajjad Hussain / AFP / Getty Images]

10-Mar-16 Practo, the Bengaluru headquartered online healthcare platform, has seen very rapid growth over the last eight years with a presence in 35 Indian cities and in countries such as Singapore, Malaysia, Indonesia and the Philippines. Backed by USD120 mn investment capital Practo aims to expand into 100 cities in India and grow as a global digital healthcare company. [Image: Notey]

11-Mar-16 The number of Indians suffering from kidney failures has doubled in the last one and a half decades. Diabetes is believed to be the most common cause and with its growth, the number of kidney patients is likely to rise. [image: Zee News]

03-Mar-16 India has one of the biggest health protection gaps amongst the countries in Asia. The gap is projected to increase by 12.3% annually to US$214 billion by 2020. India will face a shortfall in healthcare financing of close to US$43 billion in 2020, which will require additional fiscal spending or higher out-of-pocket funding by individuals. [image: Global Health Expenditure Database, WHO, Swiss Re ER&C]